New data from Dana-Farber Cancer Institute, Department of Medical Oncology illuminate research in breast cancer

Current study results from the report, 'Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases,' have been published. "The purpose of the current study was to characterize the outcomes of patients with metastatic triple-negative breast cancers, including the risk and clinical consequences of central nervous system (CNS) recurrence. Using pharmacy and pathology records, a study group of 116 patients who were treated for metastatic triple-negative breast cancer at Dana-Farber Cancer Institute between January 2000 and June 2006 was identified," scientists in the United States...

Want to see the full article?

• Purchase this article for only $3.00